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A culture system that can recapitulate myelination in vitro will not only help us better understand 
the mechanism of myelination and demyelination, but also find out possible therapeutic 
interventions for treating demyelinating diseases. Here, we introduce a simple and reproducible 
myelination culture system using mouse motor neurons (MNs) and Schwann cells (SCs). Dissociated 
motor neurons are plated on a feeder layer of SCs, which interact with and wrap around the axons 
of MNs as they differentiate in culture. In our MN-SC coculture system, MNs survived over 3 weeks 
and extended long axons. Both viability and axon growth of MNs in the coculture were markedly 
enhanced as compared to those of MN monoculture. Co-labeling of myelin basic proteins (MBPs) and 
neuronal microtubules revealed that SC formed myelin sheaths by wrapping around the axons of 
MNs. Furthermore, using the coculture system we found that treatment of an antioxidant substance 
coenzyme Q10 (Co-Q10) markedly facilitated myelination.
Myelin provides an electrically insulating material that forms a multilayered sheath around an axon of 
a neuron. In the peripheral nervous system (PNS), myelin sheath is generated by Schwann cells (SCs), 
whereas in the central nervous system (CNS), myelin is produced by oligodendrocytes. The myelin wrap-
ping of axons by SCs and oligodendrocytes not only facilitates the conduction of action potentials in the 
nervous system, but also protects axons and provides nutritional support to associated axons. As various 
defects in myelination, such as hypomyelination, delayed myelination, or demyelination, are known to 
cause serious disorders in the nervous system1–4, understanding how SCs and oligodendrocytes initially 
produce myelin during development and remyelinate axons in the diseased nervous system is of signif-
icant clinical interest. In many cases of nerve repair after physical injury, an incomplete myelination of 
regenerated nerve fibers causes malfunction of repaired nerve5.
To understand the process of myelination and remyelination, several in vitro models have been devel-
oped. Methods to culture SCs and oligodendrocytes have been established and extensively applied to 
investigate the biology of myelinating glia6–8, and these cultures greatly improved the understanding 
of how SCs and oligodendrocytes differentiate and mature. In addition to culture systems comprising 
pure SCs or oligodendrocytes, coculture systems composed of both neurons and myelinating glia should 
provide insights into the interaction between myelination glial cells and axons as well as the myelinating 
process. To this end, previous studies described coculture systems of oligodendrocytes and hippocampal 
neurons8, SCs and sensory neurons (from dorsal root ganglia)6, or oligodendrocytes and retinal gan-
glion cells9. Recently, Gingras et al.10 reported a method for culturing primary motor neurons (MNs) on 
collagen-chitosan sponges seeded with fibroblasts or with fibroblasts and Schwann cells, which enabled 
long-term culture (lasting more than a month) of MNs. However, the protocol required 21 days of 
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culture before the addition of MNs, and efficient axon outgrowth could be achieved by the addition of 
high concentrations of several exogenous neurotrophic supplements, including BDNF, neurotrophin-3, 
glial-derived neurotrophic factor, and ciliary neurotrophic factor. On the other hand, Haastert et al.11 
reported that when cultured on a feeder layer of SCs, MNs without supplementary support of neuro-
trophic factors matured in culture for 20 days in vitro (DIV), but that the fraction of MNs gradually 
reduced from higher than 70% on DIV 3 down to 12% by DIV 20. In addition, in the coculture model 
of MNs and SCs, MNs matured with enlarged somata but myelination of MN axons by SCs was not 
achieved during the culture period.
In the present study, we report a coculture system comprising primary mouse MNs and SCs. In 
our system, MNs survived for at least 3 weeks in culture and more importantly, SCs differentiated and 
formed myelin sheath around the axons of MNs. In the coculture, neurons exhibited higher viability and 
extended longer axons as compared to MN monoculture. By employing standard cell biological and bio-
chemical approaches, we have confirmed that SCs myelinate MN axons within 3 weeks of coculture. The 
formation of myelin sheath was confirmed at the ultrastructural level. Furthermore, using the MN-SC 
coculture, we show that treatment with coenzyme Q10 facilitates myelination.
Results
Establishment of a MN-SC Coculture System. To develop a long-term culture model of MNs, 
SCs were harvested from the sciatic nerves of postnatal day 4 (P4) mice and cultured on approximately 
Figure 1. Schematic illustration of MN monoculture and MN-SC coculture on a matrigel. (A) MNs 
cultured on a coverslip coated with growth factor-reduced matrigel. (B) MNs cultured on a SC feeder layer 
that grew up to 90% confluency.
Figure 2. Flowchart of the differentiation of MNs in culture. Examples of light microscopic images of MN 
monoculture and MN-SC coculture at different stages are shown. In the MN monoculture, purified neurons 
form synapses at DIV 7, but viability greatly reduces by DIV 14. In the MN-SCs coculture, SCs are cultured for 
7 days, and then MNs are grown on top of the SC feeder layer. MNs in the coculture survive for at least  
3 weeks and motor axon diameter increases (arrows, yellow). All images are at the same scale. Scale bar, 50 µm.
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3 mm-thick matrigel. SCs were cultured for a week until cells formed a confluent feeder layer. On top of 
SC feeder layer, purified MNs obtained from the ventral horns of gestation day 14 embryos (E14) were 
seeded and cocultured (Fig. 1B, MN-SC coculture). As a control, MNs were cultured directly on matrigel 
without prior culture of SCs (Fig. 1A, MN monoculture). In the MN monoculture, MNs extended axons 
up to DIV 7, but neurons gradually degenerated thereafter and by DIV 14, few MNs survived (Fig. 2). By 
contrast, in the MN-SC coculture, neurons differentiated and developed neurites and remained intact up 
to at least DIV 21. On DIV 3, we were able to detect migration of SCs toward the axons of MNs and on 
DIV 7, we observed nuclei of SCs around the axons. We also compared cell viability in MN monoculture 
and MN-SC coculture systems by using Live-Dead cell staining kit and NeuN-DAPI double antibody 
staining methods (Details in Methods section). In the MN monoculture, vast majority of neurons (96%) 
failed to survive (Fig. 3A,B). The MN-SC coculture, however, showed almost no cell death up to DIV 21 
(Fig. 3C). Furthermore, the viable MN cell number was maintained throughout the culture, whereas the 
viable SC cell number steadily increased up to DIV 21 (Fig. 3D), suggesting that SCs play a critical role 
in supporting the survival of MNs.
We next quantitatively examined the effects of SCs on axon outgrowth of MNs using TuJ1 staining 
for the nerve fibers and ImageJ to quantify the fiber length (Fig. 4). When axon length was measured at 
2 days after plating MNs (Fig. 4A), average axon length of MNs grown in the MN-SC coculture system 
was about 4 times longer than that of MN monoculture. In the MN-SC coculture, axons grew at a rate 
of about 50 μ m per day, which is consistent with a previous report7. Taken together, these results suggest 
that SCs are essential for the survival and neurite outgrowth of MNs.
Figure 3. Cell viability in MN monoculture (A and B) and MN-SC coculture (C and D). Viability was 
assessed by double-staining with calcein-AM and propidium iodide (PI) at DIV 0, 7, 14, or 21, as indicated 
(A and C). Samples were then fixed and immunostained with DAPI and NeuN antibodies (B and D). 
Representative images (A and C) and quantification of NeuN-positive MNs are shown (B and D). (n = 5), 
Scale bar, 100 µm.
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Myelination of Motor Neurons. To investigate if SCs differentiate and more importantly myelinate 
MN axons in our MN-SC coculture system, cultures were examined for expression of markers of SC 
differentiation and myelination, such as myelin basic protein (MBP), SRY-related HMGbox-10 (Sox10) 
and Krox20. We found that the expression of Sox10, a transcription factor which controls myelination 
in the PNS12, was detected in the soma of SCs on DIV 7 and increased thereafter (Fig. 5). Expression of 
MBP was detected on DIV 10, and eventually became highly localized along the axon fiber by DIV 14 
(Fig. 5, green). Western blot analysis confirmed the expression of MBP and Krox20, a transcription factor 
induced by the activation of Sox10. Krox20 is known to suppress the immature state and promote myeli-
nation13,14. We observed an increase of both MBP and Krox20 protein levels over time (Fig. 6), consistent 
with our immunocytochemistry results (Fig.  5). Next, we examined myelin sheath formation on DIV 
21 in detail by confocal microscopy and transmission electron microscopy (TEM). Z-stack images of 
confocal microscopy confirmed tight interaction between MBP and axons of MNs (Fig. 7, Supplemental 
movie 1). By taking TEM images, we confirmed that SCs formed loose sheaths by DIV 14, which could 
be the premyelination stage (Fig. 8A,B), and that SCs tightly wrapped the nerve fiber by DIV21, which 
could be the completed myelination stage (Fig.  8C,D). The thickness of compact myelin sheaths was 
approximately 0.2 μ m at DIV 21.
Distinct Stages of Myelination Observed in the MN-SC Coculture System. It is well-known 
that oligodendrocytes in the CNS differentiate from pre-myelinating to myelinating stage and the transi-
tion is controlled by several intrinsic and extrinsic signals15. Likewise, in our MN-SC coculture system, 
SC myelination proceeded through two distinct stages, which could be distinguished on the basis of 
MBP expression pattern and interaction with axons as mentioned above in the TEM images. In the 
pre-myelinating stage, expression of MBP in SCs was relatively widespread, whereas in the myelinating 
stage, MBP expression in SCs was tightly localized along the axons. By counting the number of these two 
different types of SCs under confocal microscope, we found that while most SCs were at pre-myelinating 
stage when observed on DIV 10, the number of myelinating SCs gradually increased in culture and 
reached 80% by DIV 21 (Fig. 9B).
Promotion of MN myelination by Coenzyme Q10. We next treated our coculture samples 
with drugs implicated in the treatment of neurological diseases. Samples were treated with riluzole 
(2-amino-6-(trifluoromethoxy) benzothiazole), an FDA-approved drug for the treatment of amyotrophic 
lateral sclerosis (ALS)16, a debilitating neuromuscular disease which involves the death of motor neurons, 
or with coenzyme Q10 (Co-Q10) (1,4-benzoquinone, also known as ubiquione), an antioxidant and 
mitochondrial cofactor, which has been considered as a potential therapeutic agent for demyelinating 
and neurodegenerative diseases17,18. As shown in Fig. 10A,B, Co-Q10 treatment facilitated MBP expres-
sion and increased the number of myelin-forming SCs as compared to control. When observed on DIV 
7, MBP expression was detected only in Co-Q10-treated cultures but not in control or riluzole-treated 
cultures. By DIV 14, MBP expression was also detected in control and riluzole-treated cultures, but the 
percentage of myelinating SCs was lower as compared to Co-Q10-treated cultures. By DIV 21, all cul-
tures expressed MBP. In all cultures, we detected an increase of Krox20 expression, demonstrating that 
SCs differentiate properly in our MN-SC coculture system and that treatment of riluzole or Co-Q10 did 
Figure 4. Axonal outgrowth in MN monoculture and MN-SC coculture. (A) Confocal images of MN 
monoculture and MN-SC coculture are shown. Cells were fixed and stained for s100β, TuJ1 and nucleus 
(DAPI), as indicated, at DIV 2, and lengths of axons were measured. Scale bar, 50 μm. (B) Each bar 
represents mean ± S.E. value. (n= 100) *** p < 0.001.
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not affect the transition from pre-myelinating to myelinating stage per se but perhaps control later stages 
of SC myelination (Fig. 10C).
Discussion
Several in vitro models have been previously developed to study the cellular and molecular mechanisms 
involved in the myelination process. Sensory neurons from dorsal root ganglia6,7,19,20 or retinal ganglia21 
were cocultured with SCs to induce the formation of myelin sheath in vitro. Several in vitro models for 
MN culture have also been introduced10,11,22–24, and the findings from these studies have confirmed that 
addition of exogenous neurotrophic supplements and/or a coculture with SCs or fibroblasts was critical 
Figure 5. Differentiation of neurons and SCs in MN-SC coculture. Confocal images of MN-SC coculture 
are shown. Cells were fixed and stained for Sox10, MBP, TuJ1 and nucleus (DAPI) at DIV 7, 10, and 14, as 
indicated. Note the expression of MBP protein around axons at DIV 10 and 14. Scale bar, 50 µm.
Figure 6. Increased expression of Krox20 and MBP protein in the MN-SCs coculture.  The levels 
of Krox20 and MBP were determined by western blot analysis at DIV 1, 7, 14, and 21, as indicated. 
Representative blots (A) and quantification (B) of Krox20 and MBP levels are shown. Protein levels were 
normalized against the level of α-tubulin, which was used as a loading control. Each bar represents the 
average expression level of a protein of interest normalized to that of DIV 1 (n=5).
www.nature.com/scientificreports/
6Scientific RepoRts | 5:15122 | DOi: 10.1038/srep15122
for the survival and neurite outgrowth of MNs cultured in vitro. MN cultures treated with astrocyte 
conditioned medium23 or insulin-like growth factor-122 could specifically enhance the extent and rate of 
axonal outgrowth from murine corticospinal MNs. However, to the best of our knowledge, no culture 
method to date has recapitulated the myelination process of MN by SCs in vitro. Moreover, previous 
studies have attempted to culture MNs by using NycoPrepTM, OptiPrepTM, or immunopanning dishes, 
but the purified MNs frequently failed to survive long-term11,24,25. In this study, we have aimed at con-
structing a MN-SC coculture system to model both the axon outgrowth and the myelination process of 
MN.
Here we have confirmed that SCs play an essential role in increasing the viability and promoting 
axonal outgrowth of MNs. Consistent with our results, several groups have reported that SCs enhance 
Figure 7. Formation of compact myelin sheaths in the MN-SCs coculture model.  At DIV 21, cultured 
cells were observed by confocal microscopy after immunolabeling with anti-MBP (1:500, green) and anti-
TuJ1 antibodies (1:1000, red). Images shown at the top and bottom panels are serial images collected 
throughout z-sections. Scale bar, 5 μm.
Figure 8. Myelination of axons in the MN-SC coculture model.  The extent of myelin sheaths was 
analyzed by transmission electron microscopy at DIV 14 and 21. Micrographs from DIV 14 show SCs 
loosely wrapping around the nerve fiber (A, B), whereas those from DIV 21 clearly show the formation of 
compact myelin sheaths (C). Representative image presented in D shows a heavily myelinated nerve fiber. 
Scale bar, 200 nm (A-C), 20 nm (D). N, nerve fiber; m, myelin sheaths. 
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long-term viability of peripheral neurons and protect the axonal integrity. Meyer zu Horste et al.26 have 
reported that dysfunction of SCs leads to peripheral neuropathies, and Viader et al.27 have found that 
mitochondrial function in SCs is essential not only for neuronal survival but also for normal function of 
peripheral nerves. Similarly, glial cells have been shown to play a vital role for the growth and stability of 
developing synaptic structure as well as for proper functioning of neuromuscular junction28. With regard 
to nerve injury, it is well documented that SCs play a role in promoting recovery of the injured PNS by 
providing beneficial environment to the injured neurons29,30. SCs de-differentiate, proliferate, and form 
a Bands of Büngner at the injury site, by which they guide the regrowth of the proximal axons towards 
the target31. Our results, along with the previous reports, support the notion that SCs play an essential 
role in controlling the viability, axon growth, and perhaps the functions of MNs.
Our culture enables monitoring of the pre-myelinating and myelinating stages of SCs in vitro. Signals 
released from Schwann cells are critical for myelination of peripheral nerve fibers12. NRG1 (neuregulin) 
in the axonal membrane is essential for initiating the myelination process by binding to ErbB (erythro-
blastic leukemia viral oncogene homolog) family receptors expressed in SCs, and SC-derived signals are 
thought to primarily control the wrapping process of myelin around the axon. Among them, Krox20/Egr2 
(early growth response-2), which functions downstream of Sox10 (SRY-related HMGbox-10) and is acti-
vated by Oct6 (octamer-binding transcription factor-6), is essential for activating a number of myelin 
genes and maintaining the myelinated state by blocking inhibitors of myelination. Our results in Fig. 5 
show that Sox10 expression at DIV 7 preceded MBP expression, which was observed at DIV 10. The 
results in Fig.  6 also show a gradual increase of Krox20 first detected on DIV 7, followed by a strong 
expression at a later stage (DIV 21). At later stages, MBP was highly localized along the axon fibers 
(Fig.  7). Our findings are consistent with the well-documented hierarchy of SC transcription factors 
controlling myelination (reviewed by Pereira et al.12). In our culture, we were able to confirm the sequen-
tial process of myelination, which was initiated by migration of SCs toward axons, followed by further 
differentiation of SCs, as evidenced by increased expression of MBP. Finally, SCs wrapped around axons, 
leading to the formation of thick myelin sheaths.
In the present study, we examined the efficacy of two candidate drugs, which we thought, might 
promote myelination of nerve fibers. We tested the effect of riluzole, a drug which is thought to protect 
neurons by decreasing the level of glutamate, and approved by FDA and clinically used for the treatment 
of ALS32. We also tested the effect of Co-Q10, a vitamin-like antioxidant substance that enhances ATP 
production in mitochondria. We found that while riluzole had no significant effect on myelination of MN 
axon fiber, Co-Q10 facilitated MBP expression and enhanced myelination. No positive effect of riluzole 
confirmed in our study could be explained within the context of the controversy about the efficacy of 
riluzole treatment of ALS33. SCs treated with Co-Q10 expressed MBP at an earlier stage (DIV 7), imply-
ing that Co-Q10 might accelerate myelination of nerve fibers. MNs seem to have higher energy demand 
and metabolic rate due to their increased mitochondrial activity in comparison to other neurons34. The 
Figure 9. Pre-myelinating and myelinating SCs. (A) The process of myelination. SCs envelop an axon and 
continue to produce myelin. SCs then wrap their plasma membrane loosely around an axon, yielding in 
multiple successive layers. Membrane wrappings are compacted into a tightly packed insulation coat. (B) SCs 
in culture were fixed and stained for MBP at DIV 10, 14, and 21, as indicated. MBP-expressing SCs were 
categorized into two groups, pre-myelinating and myelinating (n=5).
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stimulating effect of Co-Q10 found in our study could be due to its ATP synthesizing ability as electron 
carriers35 or the antioxidant nature of Co-Q1036,37, or a combination of both. The exact mechanism and 
efficacy of Co-Q10 warrants further studies.
Conclusions
In conclusion, we report a simple and reproducible MN-SC coculture system derived from mouse neu-
rons and glia. In the coculture, SCs enhanced cell viability and promoted axonal outgrowth of MNs. 
Moreover, SCs differentiated and transformed from pre-myelinating to myelinating stage as evidenced 
by the gradual increase in MBP expression and the localization of MBP signals along axon fibers. 
Furthermore, using the MN-SC coculture, we show that Co-Q10 accelerates myelination.
Methods
Cell Preparation. Schwann Cell (SC) Culture. All animal experiments have been conducted in 
accordance with protocols approved by the Institutional Animal Care and Use Committee (IACUC) at 
the Korea Institute of Science and Technology. SCs were isolated from sciatic nerves of CD-1 mice (P4), 
as previously described6. Explants were incubated in Ca2+- and Mg2+-free phosphate-buffered saline 
(PBS, Lonza) containing 0.05% trypsin (Sigma) and 0.05% collagenase A (Roche) for 30 min at 37 °C, 
followed by centrifugation at 190 g for 5 min. The pellets containing tissue fragments and cells were then 
washed three times with high glucose—DMEM (Gibco) containing 10% horse serum (HS) (Gibco). The 
harvested SC pellets were suspended in SC basic culture medium composed of high glucose DMEM, 
10% HS, 4 mM L-glutamine (L-gln, Invitrogen), 100 units/ml penicillin/streptomycin (P/S, Sigma), 2 ng/
ml human heregulin beta-1(Sigma), and 0.5 μ M forskolin (Sigma). After suspended, SCs were seeded on 
12 mmφ coverslips at a density of 3 × 104 cells per coverslip. Prior to seeding SCs, the coverslips were 
coated with growth factor-reduced matrigel (3 mm thickness on average). On DIV 4, complement-me-
diated cytolysis was performed to remove fibroblasts from the SC culture. Briefly, the cells were lightly 
washed with 20 mM HEPES (T&I) in Ca2 + - and Mg2 + -free HBSS solution (Invitrogen), followed by 
washing with HMEM (high-glucose DMEM containing 20 mM HEPES buffer, 10% HS, 4 mM L-gln, 
100 units/ml P/S). After washing, 4 ng/ml anti-mouse CD90 (Serotec) in HMEM was added for 15 min 
at 37 °C, and 200 μ l of rabbit human leucocyte-associated antigens A, B, C (HLA-ABC) complement sera 
(Millipore) was added for 2 hrs at 37 °C. Cytolysis was terminated by washing cells with 20 mM HEPES 
Figure 10. Effects of drug treatment on myelination. Comparison of MBP expression in MN-SC coculture 
treated with coenzyme Q10 (Co-Q10) or riluzole using immunocytochemistry. Note the marked elevation of 
pre-myelination in cultures treated with Co-Q10 at DIV 7. (n=5), * p < 0.05, Scale bar, 20 μm.
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buffer in HBSS. After the cytolysis, SCs were cultured for another three days in the SC growth medium 
containing SC basic culture medium (described above) supplemented with 10 ng/ml of bFGF (Sigma) 
and 20 μ g/ml of bovine pituitary extract (Sigma) to promote cell proliferation.
Motor Neuron (MN) Culture. MNs were harvested from the spinal cord of CD-1 mice (E14 fetus) 
as previously described24 with some modifications. Ventral horns of the spinal cord (L1-L6 segment) 
were each collected in HBSS and 1% TLR trypsin (Worthington) was added for 15 min in a 37 °C 
water bath before treating with 1% TLR trypsin inhibitor (Sigma). To extract a purified population of 
MNs, cells dissociated from the explant were treated for 45 min at room temperature with a selective 
immuno-panning dish prepared with p75NTR antibody solution (1:5000, Abcam) in 10 mM Tris-HCl 
(pH 9.5, T&I). Suspensions, including nerve fragments and p75NTR-negative cells, were removed from 
the panning dish by washing three times with pre-warmed neurobasal medium containing Glutamax 1 
(Gibco). MNs bound to the panning dish were then rinsed with depolarization solution containing 0.8% 
sodium chloride, 30 mM potassium chloride, and 2 mM calcium chloride (Merk) in distilled water for 
10 sec, and gently collected into the MN culture medium composed of neurobasal medium (Invitrogen), 
10% HS, Glutamax 1, B27 supplement (Gibco), 1 μ M β -mercaptoethanol (Sigma), and 10 ng/ml BDNF 
(Gibco). MNs were collected by gentle pipetting, and were then centrifuged for 5 min at 400 g. After 
centrifugation, the pellets were re-suspended in the MN culture medium.
Coculture of MNs and SCs. MNs were plated (1 × 104 cells/coverslip) on top of a monolayer of SC 
culture which was prepared above (Fig.  1B). We performed that MN were seeded on SC feeder layer 
on which SCs cultured on growth factor reduced-matrigel to precede both migration and wrapping 
process of SCs around axons. In order to induce myelination, MN-SCs were first cultured in a coculture 
growth medium (neurobasal medium containing 2 ~ 10% HS, B27 supplement, 0.5 mM L-gln, 0.5 ~ 1 mM 
β -mercaptoethanol, 0.5 μ M forskolin, 1 mg/ml bovine pituitary extract, 10 ng/ml BDNF) for 7 days, 
after which 25 ~ 50 μ g/ml of ascorbic acid (Sigma) was supplemented for the subsequent culture. For 
MN monoculture, MNs were cultured directly on matrigel-coated coverslips without SC feeder layer 
(Fig.  1A). For drug treatment, cultures were treated with coenzyme Q10 (Co-Q10, 1 μ M) or riluzole 
(0.1 μ M), as indicated. At 24 hr after treatment, samples were fixed and subjected to immunostaining 
with the indicated antibodies. All culture medium was replenished three times a week.
Measurement of Cell Viability. Live-Dead cell staining kit was used according to the manufacturer’s 
instructions (Abcam). Briefly, after 0, 7, and 14 days of monoculture or 7, 14, and 21 days of coculture, 
samples were labeled with mixture of solution A (Live-Dye) and solution B (PI) in the staining buffer 
for 15 min at 37 °C. The samples were then washed once with the staining buffer and examined under 
Olympus IX71 with U-RFL-T (detects FITC and TRITC). For NeuN immunostaining, cells were fixed 
with 4% paraformaldehyde (PFA) and treated with 0.2% Triton X-100 (Sigma), followed by blocking in 
4% BSA (Millipore) at 4 °C overnight. Cells were then labeled with NeuN antibody (1:500, Abcam) for 
24 hr at 4 °C, and were stained with Alexa Fluor® 488 donkey anti-mouse IgG (1:500, Invitrogen) for 
1 hr at room temperature, followed by DAPI (Life Technologies) staining. The number of stained cells 
was counted from five random fields (Live-Dead cell, NeuN staining) of view under the microscope and 
statistical analysis on the cell viability was performed.
Measurement of Axon Length. Cultures were fixed and labeled for TuJ1 to visualize axons of MNs, 
and the lengths of axons (n = 100) were measured by using ImageJ software.
Immunocytochemistry. After 7, 14, and 21 days of coculture, all samples were fixed with 4% para-
formaldehyde (PFA) for 15 min at room temperature and washed twice with PBS. The fixed samples were 
then soaked in PBS containing 0.2% Triton X-100 (Sigma), followed by 4% BSA (Millipore) at 4°C over-
night and labeled with primary antibodies, which included anti-Sox10 (1:500, Abcam), anti-s100β (1:500, 
Abcam), anti-β -III Tubulin (Tuj1, 1:1000, Abcam), and anti-myelin basic protein (MBP, 1:500, Abcam). 
All samples with primary antibodies were incubated in 1% BSA with PBS at 4°C overnight. The samples 
were then washed with PBS containing 1% BSA twice, and incubated with goat anti-chicken IgY H&L 
(1:1000, Abcam), goat anti-rabbit IgG H&L (1:500, Abcam), or Alexa Fluor® 488 donkey anti-mouse IgG 
(1:500, Invitrogen). The nuclei of cells were stained with DAPI (Life Technologies) for 15 min at room 
temperature. Fluorescence of the culture was visualized under a confocal microscope (Zeiss LSM 700).
Western Blot Assays. Expressions of MBP and Krox20 were quantitatively analyzed by using western 
blot analysis. The cells at DIV 1, 7, 14, and 21 were lysed in RIPA buffer containing 1% SDS and protease 
inhibitor (aprotinin, leupeptin, pepstatin A, PMSF). The protein concentration of cell lysates was meas-
ured by using Bradford assay. The samples were prepared in an SDS sample buffer, heated for 3 min at 
98 °C, and 6 μ g of the protein from each sample were loaded in SDS loading buffer and then transferred 
to a PVDF membrane. The membranes were blocked in 2.5% skim milk for 1 hr, followed by incubation 
with anti- rabbit Krox20 (1:1000, Abcam) or anti- rat MBP (1:500, Abcam) antibodies at 4 °C overnight. 
The membranes were washed three times in TBST and incubated with goat anti-rabbit and anti- rat IgG 
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conjugated to horseradish peroxidase (1:1000, Sigma) for 2 hrs. Bands were visualized by using ECL 
system. The intensity of the blots was quantified with ImageJ software.
Transmission Electron Microscopy. At DIV 14, 21, cultures were fixed with 4% glutaraldehyde in 
PBS and stored at 4 °C overnight, and postfixed with 1% osmium tetroxide for 30 min. Samples were 
embedded in pre epoxy resin before dehydration with a series of ethanol solutions (70%, 80%, 85%, 
90%, 95%, 100%). Sections were taken between 70 ~ 80 nm using Ultramicotome (Leica, Ultra Cut C) 
and picked up on Cu grids, stained in uranyl acetate and lead citrate. Images were acquired with the 
Cryo-TEM (FEI, CryoTecnai F20).
Quantitative Analysis of Pre-myelinating and Myelinating Schwann Cells. During coculture, 
cultures immunostained with anti-MBP antibodies showed two distinct patterns of MBP expression: 
pre-myelinating SCs showed relatively wide-spread expression of MBP adjacent to the axons while mye-
linating SCs showed highly localized expression of MBP along the axons. Cocultures were stained with 
MBP and TuJ1 at DIV 10, 14, and 21 and the proportion of these two types was calculated from six 
different fields of view under confocal microscope.
Statistical Analysis. Average data are shown as mean ± standard error and the comparison between 
different groups were performed by using repeated measurement analysis of variance (ANOVA), and 
statistical significance was set at a value of *P < 0.05, ***p < 0.001.
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